Medication info

Infusajung 5/160mg

Prescription medicationTabletOral
Ingredient · strength
Valsartan›160mg / 1 tabletAmlodipine Besylate›6.935mg / 1 tablet
Manufacturer / importer
Introbiopharma Co., Ltd.
Appearance
Dark yellow egg-shaped film-coated tablet
Packaging
30 tablets/PTP (10 tablets/PTP*3)
Approval status
Active

MFDS item code 201603881 · Approved 2016.06.24

Summary

Main use
Treatment of essential hypertension not controlled by monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose is 1 tablet once daily, taken with water, regardless of meals. It is recommended that the tablet be taken at the same time each day (e.g., in the morning), if possible. Before starting this medication, it is recommended that the dose be adjusted using the individual components (amlodipine or valsartan). However, if blood pressure is not controlled with monotherapy using either component, switching directly to this medication may be considered as follows. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. Patients taking valsartan and amlodipine concomitantly may switch to this medication (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or more). However, this medication should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. This medication should not be administered to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Patients aged 65 years or older: Use caution when increasing the dose.
Child dose
The use of this medication is not recommended in pediatric patients under 18 years of age, as its safety and efficacy have not been established.

Ingredients

Manufacturer
Introbiopharma Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled by monotherapy

  • Essential hypertension
View approved original text

This drug is used to effectively manage blood pressure in patients with essential hypertension whose blood pressure is not adequately controlled with monotherapy using amlodipine or valsartan.

How to take

Adult dose

The recommended dose is 1 tablet once daily, taken with water, regardless of meals. It is recommended that the tablet be taken at the same time each day (e.g., in the morning), if possible. Before starting this medication, it is recommended that the dose be adjusted using the individual components (amlodipine or valsartan). However, if blood pressure is not controlled with monotherapy using either component, switching directly to this medication may be considered as follows. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. Patients taking valsartan and amlodipine concomitantly may switch to this medication (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or more). However, this medication should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. This medication should not be administered to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Patients aged 65 years or older: Use caution when increasing the dose.

Child dose

The use of this medication is not recommended in pediatric patients under 18 years of age, as its safety and efficacy have not been established.

Precautions

This medication can cause serious harm to the fetus or newborn if taken during the second or third trimester of pregnancy; therefore, it should be discontinued immediately upon confirmation of pregnancy. Patients with allergies to the active ingredients or similar classes of drugs, pregnant or breastfeeding women, patients with severe renal or liver dysfunction, or those with a history of certain heart conditions or angioedema should not take this medication. Patients with sodium or fluid depletion may experience hypotension, so their condition should be stabilized before taking this medication, and blood pressure and condition should be closely monitored during treatment. Patients with high potassium levels are at greater risk of further increasing potassium levels when taking this medication with potassium supplements or potassium-sparing medications and should be monitored regularly through blood tests. Patients with renal vascular problems or those who have recently undergone kidney transplantation should take this medication cautiously, as there is a risk of worsening renal function, and renal function tests are necessary according to the physician's guidance. If symptoms of angioedema, such as swelling of the face, lips, or tongue occur while taking this medication, discontinue immediately and inform healthcare personnel. Patients who have experienced heart failure or myocardial infarction should closely monitor changes in renal function and blood pressure while taking this medication, ensuring that heart failure symptoms do not worsen. Side effects such as dizziness, headaches, swelling, dyspepsia, skin rashes may occur in some patients, and if any unusual symptoms arise, consultation with a physician is recommended. Care should be taken as dizziness and fatigue may occur while driving or operating machinery. This medication may interact with other antihypertensive medications or specific drugs; therefore, all medications being taken should be disclosed to healthcare personnel, and regular checks of blood pressure, renal function, and electrolyte levels should be performed as necessary. Pregnant women or those planning to become pregnant should not use this medication, and breastfeeding women should avoid taking it as well. The safety and efficacy of this medication in patients under 18 years of age have not been adequately established, and its use is not recommended. In the event of an overdose, severe hypotension or heart problems may occur, so the prescribed dosage must be adhered to, and emergency medical attention should be sought if unusual symptoms appear.

Side effects

nasopharyngitis, influenza, hypersensitivity, visual disturbances, anxiety, headache, dizziness, drowsiness, positional dizziness, paresthesia, vertigo, tinnitus, tachycardia, palpitations, syncope, orthostatic hypotension, hypotension, cough, throat and laryngeal pain, diarrhea, nausea, abdominal pain, constipation, dry mouth, rash, erythema, hyperhidrosis, pruritus, joint swelling, low back pain, arthritis, muscle spasms, lethargy, polyuria, excessive urination, erectile dysfunction, edema, localized edema, facial edema, peripheral edema, fatigue, flushing, asthenia, facial flushing, decreased hemoglobin, decreased hematocrit, neutropenia, thrombocytopenia, hypersensitivity including serum sickness, increased serum potassium, vasculitis, elevated liver function tests, angioedema, myalgia, renal failure, kidney damage, increased serum creatinine, insomnia, decreased libido, pharyngitis, rhinitis, sinusitis, upper respiratory infection, viral infection, diplopia, thrombocytopenia, leukopenia, allergic reactions, hyperglycemia, insomnia, mood changes, tremors, sensory impairment, taste disturbances, peripheral neuropathy, hypertonia, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, myocardial infarction, dyspnea, rhinitis, vomiting, dyspepsia, pancreatitis, gastritis, gingival hyperplasia, hepatitis, jaundice, alopecia, purpura, skin depigmentation, photosensitivity reactions, urticaria, erythema multiforme, Stevens-Johnson syndrome, myalgia, urinary disorders, nocturia, gynecomastia, pain, malaise, chest pain, weight loss, weight gain, chest discomfort, abdominal discomfort, gastroesophageal reflux disease, neck pain, hypercholesterolemia, hypoglycemia, neuroirritability, Stevens-Johnson syndrome, chest pain, weight gain, arthralgia, skeletal pain, rhabdomyolysis, gingival hyperplasia, gastritis, sensory impairment

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture. Additionally, it is recommended to store the medication at room temperature between 1°C and 30°C.

Appearance and packaging

Appearance

Dark yellow egg-shaped film-coated tablet

Package unit

30 tablets/PTP (10 tablets/PTP*3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.